MedTrace Logo

Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma Patients-2 (GERIAD2)

NCT03211702 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-02-03

No results posted yet for this study

Summary

This study will validate the impact of comprehensive geriatric assessments using activity of daily living (ADL), instrumental activity of daily living (IADL), and Charlson's comorbidity index (CCI) on survival and toxicities in Korean patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP.

Conditions

  • Lymphoma, Large B-cell, Diffuse

Sponsors & Collaborators

  • The Catholic University of Korea

    collaborator OTHER

  • Kyungpook National University Hospital

    collaborator OTHER

  • Keimyung University Dongsan Medical Center

    collaborator OTHER

  • Korea University Anam Hospital

    collaborator OTHER

  • Korea University Guro Hospital

    collaborator OTHER

  • Kosin University Gospel Hospital

    collaborator OTHER

  • Pusan National University Hospital

    collaborator OTHER

  • Soonchunhyang University Hospital

    collaborator OTHER

  • Ajou University School of Medicine

    collaborator OTHER

  • Chonnam National University Hospital

    collaborator OTHER

  • Chungnam National University Hospital

    collaborator OTHER

  • Yeungnam University Hospital

    collaborator OTHER

  • Chonbuk National University Hospital

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-25
Primary Completion
2018-04-30
Completion
2020-12-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03211702 on ClinicalTrials.gov